Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service

Several studies have demonstrated the cost-effectiveness of genetic testing for surveillance and treatment of carriers of germline pathogenic variants associated with hereditary breast/ovarian cancer syndrome (HBOC). In Brazil, seventy percent of the population is assisted by the public Unified Heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Matta, Bruna Palma, Gomes, Renan, Mattos, Daniel, Olicio, Renata, Nascimento, Caroline Macedo, Ferreira, Gerson Moura, Brant, Ayslan Castro, Boroni, Mariana, Furtado, Carolina, Lima, Valdirene, Moreira, Miguel Ângelo Martins, dos Santos, Anna Cláudia Evangelista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633799/
https://www.ncbi.nlm.nih.gov/pubmed/36329109
http://dx.doi.org/10.1038/s41598-022-23012-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633799/
https://www.ncbi.nlm.nih.gov/pubmed/36329109
http://dx.doi.org/10.1038/s41598-022-23012-3

Ejemplares similares